logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

COMPASS Pathways plc

CMPS

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited anā€¦ read more

Healthcare

Medical Care Facilities

3 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$4.32

Price

+1.89%

$0.08

$4.24

Previous Close

$4.25

Open

Premium

52w Discount
Market Cap

$404.293m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$0.00

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$138.555m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.61

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$162.555m

$293.536m

Assets

$130.981m

Liabilities

$35.288m

Debt
Debt to Assets

12.0%

-0.2x

Debt to EBITDA
Free Cash Flow

-$148.288m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.